Melanoma whole-exome sequencing identifies V600EB-RAF amplification-mediated acquired B-RAF inhibitor resistance 论文

2012Nature Communications引用 619顶会
DOIPDF
Melanoma and MAPK PathwaysHER2/EGFR in Cancer ResearchComputational Drug Discovery Methods
Computational Drug Discovery MethodsMelanoma and MAPK PathwaysHER2/EGFR in Cancer Research
相关技术:Computational Drug Discovery Methods
关系图谱

Melanoma whole-exome sequencing identifies V600EB-RAF amplification-mediated acquired B-RAF inhibitor resistance · 相关文章

暂无数据